Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-04-21
1990-01-23
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548122, C07D29104, A01K 3141
Patent
active
048958620
ABSTRACT:
This invention relates to novel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides, to the processes for their preparation, to methods for using the compounds, and to pharmaceutical preparations thereof. The compounds have pharmaceutical properties which render them beneficial for the treatment of diabetes mellitus and associated conditions.
REFERENCES:
patent: 3118903 (1964-01-01), Schmitt
patent: 4148801 (1979-04-01), Santilli
Eloy, Bull. Soc. Chim., Belger 74 129(1965) Abstract.
A. Dondoni et al, J. Org. Chem., 42 (21), 3372-3377 (1977).
A. Y. Chang et al, Diabetes, 32, 830-838 (1983).
Alessi Thomas R.
Dolak Terence M.
American Home Products Corp.
Gerstl Robert
Patton Walter
LandOfFree
Novel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-645464